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Gαo (GNAO1) encephalopathies: plasma membrane vs. Golgi 
functions
Gonzalo P. Solis and Vladimir L. Katanaev
Heterotrimeric G proteins are key signaling 
molecules best recognized as the immediate transducers 
of GPCRs (G protein coupled receptors). A heterotrimeric 
G protein complex consists of three subunits, α, β, 
and γ, of which the Gα is responsible for binding to 
guanine nucleotides and to the cognate GPCR. Ligand-
activated GPCRs catalyze the GDP-GTP exchange on 
Gα inducing the dissociation of Gα-GTP from Gβγ, both 
being competent to engage downstream effectors. GTP 
hydrolysis returns the Gα to its GDP-bound state allowing 
the formation of the heterotrimeric G protein, which binds 
the cognate GPCR for a subsequent activation cycle.
During the last five years, whole-exome sequencing 
of patients with severe infantile encephalopathies resulted 
in an avalanche of de novo heterozygous mutations 
in GNAO1 [1]. GNAO1 encodes for Gαo, the major 
Gα subunit in the mammalian brain. Gαo is one of the 
sixteen human α-subunits and transduces the signal of 
a group of rhodopsin-like GPCRs including adrenergic, 
dopaminergic, opioid, and muscarinic receptor subtypes 
[2]. Gαo knockout (KO) mice showed a strong 
developmental delay during the first 3 weeks after birth, 
multiple neurological abnormalities such as hyperalgesia, 
hyperactivity, generalized tremor with occasional seizures, 
and a severe impairment of motor control [2]. At the 
cellular level, dorsal root ganglion cells derived from Gαo 
KO mice presented a reduced inhibition of Ca2+ channel 
currents by the activation of opioid receptors. Gαo is 
additionally implicated in the regulation of Ca2+ and K+ 
channels in sensory and hippocampal neurons [2].
It has been proposed that Gαo encephalopathies 
possess a strong genotype-phenotype association, with 
a group of mutations causing developmental delay and 
movement disorders, and another group responsible for 
the more severe cases of epileptic encephalopathy and 
Ohtahara syndrome [3]. Thus far, the vast majority of the 
cases is associated to single point mutations in 16 highly 
conserved residues [1], pointing to their involvement in 
basic Gαo functions. The remaining two cases correspond 
to a deletion of seven amino acids and a predicted splicing 
defect [1]. A recent study indicates that mutations in 
eight of the 16 residues cause varying degrees of loss-
of-function downstream of the α2A adrenergic receptor 
[4]. Somehow contradictory, a previous study showed 
that two of these residues do not induce any significant 
defects compared to wild type Gαo in the inhibition 
of Ca2+ currents by norepinephrine [5]. Intriguingly, 
mutations in other five residues did not compromise (or 
only slightly affected) α2A adrenergic receptor signaling 
[4]. Thus, it is highly plausible that Gαo functions beyond 
its canonical role as GPCR-transducer also contribute to 
the development of Gαo encephalopathies.
The functional localization of heterotrimeric G 
proteins at the plasma membrane (PM) is widely accepted. 
However, an increasing amount of data indicate that they 
also work at different cellular compartments, especially 
at the Golgi apparatus [6]. Recently, we identified >250 
proteins as potential Gαo interacting partners, and 
subsequently uncovered a non-canonical Gαo signaling 
involved in the regulation of vesicular trafficking at the 
Golgi [7]. We showed that two pools of Gαo – at the 
PM and Golgi – coexist and act coordinately in cellular 
processes such as neuritogenesis: the PM Gαo locally 
initiates neurite formation, and the Golgi Gαo ensures 
              Editorial
Figure 1: Gαo mutations affecting differently its 
PM and Golgi functions as the potential origin of 
the varying degrees of severity observed in GNAO1 
encephalopathies.
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material delivery for neurites to grow (Figure 1). We 
nailed down a novel mechanism of unconventional 
interactions at the Golgi, where an atypical GPCR (KDEL 
receptor) stimulates Gβγ-free Gαo, which in turn activates 
the small GTPases Rab1 and Rab3. This pathway is highly 
conserved from fly to human, and is also required for 
synaptogenesis in vivo [7].
Remarkably, mutations in the Gαo-coupled α2B 
adrenergic receptor are linked to a familial epilepsy 
(ADRA2B, OMIM:607876 [8]), and several de novo 
mutations in the heterotrimeric Gβ1 are associated to 
severe neurodevelopmental disorders often accompanied 
by seizures (GNB1, OMIM:616973). On the other hand, 
some of the Golgi partners of Gαo [7] have been involved 
in diverse neuropathies characterized by developmental 
delay and intellectual disability but not seizures (i.e. 
COG6, OMIM:615328; AP1S1, OMIM:609313; GDI1, 
OMIM:300849). Therefore, it is tempting to speculate that 
different degrees of severity in GNAO1 encephalopathies 
reflect the extent in which the PM vs. Golgi functions 
of Gαo are affected by a particular mutation (Figure 
1). We hypothesize that mutations targeting mainly the 
canonical GPCR-mediated signaling of Gαo induce the 
most severe cases of epileptic encephalopathy, whereas 
mutants affecting predominantly its Golgi role develop 
neurodevelopmental delay, intellectual disability and 
movement disorders.
To conclude, the next challenge to eventually 
complete our understanding of the etiology of GNAO1 
encephalopathies is the generation of a tractable animal 
model to study the Gαo pathways that control development 
and physiology of the central nervous system. Such a 
model should allow for large screening of chemicals to 
identify hit compounds in order to develop personalized 
drugs against Gαo encephalopathies.
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